Search Site

Trends banner

Emirates expects first 777X delivery in H2 2026

Boeing had pushed back the first delivery to 2026 from 2025.

Aramco, unit and Sinopec ink $4bn deal

The two companies will establish a joint venture company.

Etihad unveils new A321LR aircraft

A321LR features First Suite - a private, enclosed space with a sliding door.

stc Group Q1 net profit up 11.05%

The Group reported a revenue of $5.12 billion.

SAIB reports $139 million Q1 net profit

its assets increased by 20.08 percent to $43.65bn.

Burjeel IPO raises $300m

The IPO was oversubscribed 29 times. (Burjeel)
  • Oversubscribed 29 times, the total gross demand for the IPO was more than AED32 billion ($8.7 billion).
  • Based on the Final Offer Price, Burjeel’s market capitalization upon listing is expected to be approximately AED10.4 billion.

Abu Dhabi, UAE—Burjeel Holding, the Abu Dhabi based healthcare provider, said it raised more than AED1.1 billion ($300 million) from the sale of an 11 per cent stake sale in the company’s initial public offering (IPO).

Oversubscribed 29 times, the total gross demand for the IPO was more than AED32 billion ($8.7 billion), the company said and added that more than 550.7 million shares at the share price of AED2.

Based on the Final Offer Price, Burjeel’s market capitalization upon listing is expected to be approximately AED10.4 billion, making it one of the largest private healthcare companies on ADX by market capitalization, the company said.

Its shares will begin trading on October 10 under the symbol “BURJEEL”. VPS Healthcare Holdings will continue to own a 70 per cent stake in the company after the listing.

Burjeel Holdings, founded in 2007 by Dr Shamsheer Vayalil, has a network of about 61 assets, including hospitals and medical centres, as well as pharmacies and other allied services throughout the UAE and Oman.

Dr. Shamsheer Vayalil Parambath, Founder and Chairman of Burjeel Holdings, said, “The strong demand for the IPO reflects the high-quality investment opportunity provided by Burjeel Holdings, built around our clear clinical vision and our strong growth trajectory in the MENA region.”